ProNoxis AB
556773-2341ActiveDeveloping small molecule drugs targeting NOX2 activation for inflammation treatment.
Overview
- 1
- Employees
- 212K SEK
- Revenue
- 2008
- Founded
Key Decision Makers
Peter Olofsson
CEO
Description
ProNoxis is a specialized biotechnology company focused on the preclinical exploration of novel small-molecule therapeutics. Its core mission is developing oral drugs to treat chronic inflammatory, autoimmune, and infectious diseases. The company targets a unique mechanism by developing agonists tha...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556773234101
Decision Makers
1 contacts in FunnelfeedrPeter Olofsson
CEO
Similar Companies
20 similar companies in FunnelfeedrRedoxis AB
19 employeesSwedish CRO specializing in preclinical autoimmune and inflammatory disease models.
Inicure AB
0 employeesDeveloping novel small molecules to combat resistant bacterial infections effectively.
Active Biotech AB (publ)
1–4 employeesDeveloping novel treatments for cancer and inflammatory eye diseases.
VACARA AB
1–4 employeesSwedish biotech developing RA diagnostics, vaccines, and therapeutics.
Novakand Pharma AB
5–9 employeesDeveloping novel small-molecule drugs for inflammation and cancer.
Browse More
ProNoxis AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo